RxSight, Inc. (RXST)
$4.81-0.82%Close
SELLCRISIS · day 25
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $199M
- Beta
- 1.16
- P/E (TTM)
- -4.12
- Short % float
- 10.46%
- Days to cover
- 4.6
- SI change
- +2.8%
- 1W
- +2.78%
- 1M
- -19.30%
- vs SPY 1W
- +1.62%
- vs SPY 1M
- -22.29%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RXST?
- LOPJLB’s latest quantitative signal on RxSight, Inc. (RXST) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RXST in?
- RxSight, Inc. (RXST) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does RxSight, Inc. (RXST) do?
- As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of t…